Repro Med Systems Inc
NASDAQ:KRMD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Repro Med Systems Inc
Free Cash Flow
Repro Med Systems Inc
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Repro Med Systems Inc
NASDAQ:KRMD
|
Free Cash Flow
-$494.1k
|
CAGR 3-Years
61%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Free Cash Flow
$3.7B
|
CAGR 3-Years
57%
|
CAGR 5-Years
30%
|
CAGR 10-Years
35%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Free Cash Flow
$1.3B
|
CAGR 3-Years
12%
|
CAGR 5-Years
16%
|
CAGR 10-Years
12%
|
|
|
Stryker Corp
NYSE:SYK
|
Free Cash Flow
$4.3B
|
CAGR 3-Years
28%
|
CAGR 5-Years
9%
|
CAGR 10-Years
20%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Free Cash Flow
$7.4B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
15%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Free Cash Flow
$2.5B
|
CAGR 3-Years
37%
|
CAGR 5-Years
17%
|
CAGR 10-Years
13%
|
|
Repro Med Systems Inc
Glance View
Repro-Med Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. The company is headquartered in Chester New York, New York and currently employs 77 full-time employees. The company is focused on the developing, manufacturing, and commercializing of specialty infusion solutions. The firm's products include the FREEDOM Infusion Systems, which consist of the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgHFlo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The FREEDOM System operates at a lower pressure and maintains a balance between what a patient’s subcutaneous tissues can absorb and what the system delivers. The firm performs product assembly, calibration, pre- and post-assembly quality control inspection and testing, and final packaging for all its products at its Chester, New York facility.
See Also
What is Repro Med Systems Inc's Free Cash Flow?
Free Cash Flow
-494.1k
USD
Based on the financial report for Dec 31, 2025, Repro Med Systems Inc's Free Cash Flow amounts to -494.1k USD.
What is Repro Med Systems Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
23%
Over the last year, the Free Cash Flow growth was 70%. The average annual Free Cash Flow growth rates for Repro Med Systems Inc have been 61% over the past three years , 23% over the past five years .